Kenneth Bate, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 19,400 shares at $368.56 ($7.1M) on 2025-08-15, disclosed to the SEC on 2025-08-15.
Open-market sale of $7.1M MDGL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $363.41 | 2,317 | $842K | 11.9% |
| 2 | $363.41 | 2,317 | $842K | 11.9% |
| 3 | $364.24 | 2,516 | $916K | 12.9% |
| 4 | $364.24 | 2,516 | $916K | 12.9% |
| 5 | $365.33 | 2,567 | $938K | 13.2% |
| 6 | $365.33 | 2,567 |
| $938K |
| 13.2% |
| 7 | $366.14 | 600 | $220K | 3.1% |
| 8 | $367.63 | 1,104 | $406K | 5.7% |
| 9 | $367.63 | 1,104 | $406K | 5.7% |
| 10 | $368.56 | 896 | $330K | 4.7% |
| 11 | $368.56 | 896 | $330K | 4.7% |
| Total | $365.17 avg | 19,400 | $7.1M | 100% |
| Filing → |
| MDGL | SELL | 2024-04-03 | $16.0M | — | Filing → |
| CBST | SELL | 2014-02-04 | $451K | — | Filing → |
| CBST | SELL | 2014-01-09 | $700K | — | Filing → |